Profil
Christopher W.
Morgan is currently Director at Alpha Cancer Technologies, Inc. Formerly, Mr. Morgan was Director at Spectra7 Microsystems, Inc. from 2021 to 2025 and Partner at Skadden, Arps, Slate, Meagher & Flom LLP.
Mr. Morgan earned an MBA from the University of Toronto.
Postes actifs de Christopher Morgan
| Sociétés | Poste | Début |
|---|---|---|
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher Morgan
| Sociétés | Poste | Fin |
|---|---|---|
| SPECTRA7 MICROSYSTEMS INC. | Directeur/Membre du Conseil | 28/04/2025 |
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Corporate Officer/Principal | - |
Formation de Christopher Morgan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Commercial Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spectra7 Microsystems, Inc.
Spectra7 Microsystems, Inc. SemiconductorsElectronic Technology Manufactures semiconductor products | Electronic Technology |
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Health Technology |
















